Goods and services:

History and publication details:

1) Date: 2025-02-12
Display name: Status change to Voided
2) Date: 2023-01-19
Display name: International Registration in Australia Protected correspondence sent
3) Date: 2023-01-18
Display name: IP Right Registration Published
4) Date: 2023-01-18
Display name: Status change to Registered/Protected
5) Date: 2022-11-12
Display name: Application Accepted correspondence sent
6) Date: 2022-11-11
Display name: IP Right has been Examined
7) Date: 2022-11-11
Display name: IP Right Acceptance Published
8) Date: 2022-11-11
Display name: Status change to Accepted
9) Date: 2022-11-04
Display name: Examination expedited
10) Date: 2022-11-04
Display name: Awaiting examination
11) Date: 2022-11-03
Display name: IP Right Filed Published
12) Date: 2022-11-03
Display name: Status change to Published
13) Date: 2022-11-03
Display name: Status change to Filed
14) Date: 2022-11-03
Display name: Application Received
15) Date: 2022-11-03
Display name: IP right goods and service classes updated
Description: Class Count: 1 Class Numbers:5
Previous details: Class Count: 0 Class Numbers:
New details: Class Count: 1 Class Numbers: 5
16) Date: 2022-11-03
Display name: IP Right Goods and Services Items updated
Description: Class Number: 5
Previous details:
New details: Class Number: 5 Class Items: Pharmaceutical formulations and preparations to treat acute and chronic health conditions related to gastrointestinal, inflammatory, metabolic, endocrine, immunological, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, oncological, hepatological, respiratory, neurological, psychiatric, dermatological, and viral diseases and disorders; pharmaceutical compositions in liquid form, namely, liquid compositions containing protease inhibitors, to treat health conditions, diseases, and disorders related to the gastrointestinal tract, gastrointestinal permeability, the gastrointestinal epithelial barrier, gastrointestinal inflammation, the gastrointestinal immune system, the microbiome, and the gut-brain axis; pharmaceutical formulations and preparations to treat or prevent surgical complications and postsurgical complications; pharmaceutical formulations and preparations to treat or prevent shock, namely, acute shock, cardiogenic shock, septic shock, hemorrhagic shock, and shock associated with hypoperfusion; pharmaceutical formulations and preparations to treat or prevent gastrointestinal dysfunction, gastrointestinal tract injuries, ileus, and adhesions; pharmaceutical formulations and preparations to accelerate the time to return of bowel function in patients undergoing abdominal surgery; pharmaceutical formulations to reduce the formation of adhesions following abdominal or pelvic surgery; pharmaceutical formulations and preparations to treat or prevent multiorgan failure; pharmaceutical formulations and preparations to treat or prevent health conditions, diseases, and disorders related to intestinal permeability, the microbiome, and the gut-brain axis.
17) Date: 2022-11-03
Display name: Status change to Received
18) Date: 2022-11-03
Display name: Trade mark representation updated